Aspira Women’s Health Reports Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Allied World Assurance (AWH) Reports Q4 Loss of $0.58/sh
March 25, 2021 4:28 PM EDTAllied World Assurance (NASDAQ: AWH) reported Q4 EPS of ($0.58), versus ($0.03) reported last year. Revenue for the quarter came in at $1.45 million, versus $1.3 million reported last year.
For earnings history and earnings-related data on Allied World Assurance (AWH) click here.
... MoreAllied World Assurance (AWH) Announces Agreement for Development and Commercialization of Early-Detection Test for Identification of Ovarian Cancer
March 25, 2021 4:26 PM EDTAspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced it has entered into an agreement with Dana-Farber Cancer Institute (DFCI), Brigham and Womens Hospital, and Medical University Lodz to evaluate their novel microRNA (miRNA) technology in combination with current AWH technologies, for the development of a highly sensitive and specific high-risk early detection test for ovarian cancer. Ovarian cancer accounts for more deaths than any other cancer of the female reproductive system and is the only gender-specific cancer with an over 50 percent mortality rate... More
